Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan;126(1):148-154.
doi: 10.1016/j.radonc.2017.11.022. Epub 2017 Dec 12.

Exposure of the lungs in breast cancer radiotherapy: A systematic review of lung doses published 2010-2015

Affiliations

Exposure of the lungs in breast cancer radiotherapy: A systematic review of lung doses published 2010-2015

Marianne C Aznar et al. Radiother Oncol. 2018 Jan.

Abstract

Background and purpose: We report a systematic review of lung radiation doses from breast cancer radiotherapy.

Methods and materials: Studies describing breast cancer radiotherapy regimens published during 2010-2015 and reporting lung dose were included. Doses were compared between different countries, anatomical regions irradiated, techniques and use of breathing adaptation.

Results: 471 regimens from 32 countries were identified. The average mean ipsilateral lung dose (MLDipsi) was 9.0 Gy. MLDipsi for supine radiotherapy with no breathing adaption was 8.4 Gy for whole breast/chest wall (WB/CW) radiotherapy, 11.2 Gy when the axilla/supraclavicular fossa was irradiated, and 14.0 Gy with the addition of internal mammary chain irradiation; breathing adaptation reduced MLDipsi by 1 Gy, 2 Gy and 3 Gy respectively (p < 0.005). For WB/CW radiotherapy, MLDipsi was lowest for tangents in prone (1.2 Gy) or lateral decubitus (0.8 Gy) positions. The highest MLDipsi was for IMRT in supine position (9.4 Gy). The average mean contralateral lung dose (MLDcont) for WB/CW radiotherapy was higher for IMRT (3.0 Gy) than for tangents (0.8 Gy).

Conclusions: Lung doses from breast cancer radiotherapy varied substantially worldwide, even between studies describing similar regimens. Lymph node inclusion and IMRT use increased exposure, while breathing adaptation and prone/lateral decubitus positioning reduced it.

Keywords: Breast cancer; Breathing adaptation; Imrt; Lung dose.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The process of study identification for the review.
Fig. 2
Fig. 2
Mean ipsilateral lung dose (MLDipsi) from left or right tangential breast cancer radiotherapy according to country, gross national income per person in the country concerned, calendar year, and whether the radiotherapy plans were actually delivered or just planned. Regimens that irradiated the internal mammary chain, partial breast, axilla, or supraclavicular fossa were excluded, as were regimens with breathing adaptation, prone or lateral decubitus positioning and studies of women with unfavourable anatomy. *Average of mean ipsilateral lung doses for reported regimens. †Range of mean ipsilateral lung doses for reported regimens. χ2 and p values are for: heterogeneity (a), difference (b, d) or trend (c). For (d), the category “Not specified” was omitted from the χ2. Abbreviations: SE: standard error; CI: confidence interval.
Fig. 3
Fig. 3
Mean ipsilateral lung dose (MLDipsi) from left or right breast cancer radiotherapy according to regions irradiated. Studies of women with unfavourable anatomy were excluded as were regimens using prone or lateral decubitus positioning, and regimens irradiating the internal mammary chain (IMC) but not the axilla or the supraclavicular fossa (SCF). *Average of mean ipsilateral lung doses for reported regimens. †Range of mean ipsilateral lung doses for reported regimens. χ2 and p values are for heterogeneity. Abbreviations: SE: standard error; CI: confidence interval.
Fig. 4
Fig. 4
Mean ipsilateral lung dose (MLDipsi) from left or right breast cancer radiotherapy according to regions irradiated and technique used. Regimens using breathing adaptation (e.g. deep inspiration breath hold) were excluded, as were studies of women with unfavourable anatomy and regimens irradiating the internal mammary chain (IMC) but not the axilla or the supraclavicular fossa (SCF). *Average of mean ipsilateral lung doses for reported regimens. †Range of mean ipsilateral lung doses for reported regimens. ‡Static field IMRT and rotational IMRT are included jointly as “IMRT”. § “Other” techniques included two dynamic conformal arc therapy regimens and one unspecified 3D conformal regimen. χ2 and p values are for heterogeneity. Abbreviations: SE: standard error; CI: confidence interval; IMRT: intensity modulated radiotherapy. IMC: internal mammary chain. SCF: supraclavicular fossa.
Fig. 5
Fig. 5
Mean ipsilateral lung doses (MLDipsi) from left or right breast cancer radiotherapy with or without breathing adaptation according to regions irradiated and regimens used. Only studies providing doses with and without breathing adaptation in the same woman were included. Studies of women with unfavourable anatomy were excluded. *Average of mean ipsilateral lung doses for reported regimens. †Range of mean ipsilateral lung doses for reported regimens. ‡Static field IMRT and rotational IMRT are included jointly as “IMRT”. § “Other” includes one unspecified 3D conformal regimen. p values are calculated using a paired t-test. Abbreviations: CI: confidence interval; IMRT: intensity modulated radiotherapy; IMC: internal mammary chain; SCF: supraclavicular fossa.

Similar articles

Cited by

References

    1. McGale P., Taylor C., Correa C. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: Meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383:2127–2135. - PMC - PubMed
    1. Darby S., McGale P., Correa C. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet. 2011;378:1707–1716. - PMC - PubMed
    1. Early Breast Cancer Trialists’ Collaborative Group Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet. 2005;366:2087–2106. - PubMed
    1. Henson K.E., McGale P., Taylor C., Darby S.C. Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer. Br J Cancer. 2013;108:179–182. - PMC - PubMed
    1. Grantzau T., Overgaard J. Risk of second non-breast cancer after radiotherapy for breast cancer: A systematic review and meta-analysis of 762,468 patients. Radiother Oncol. 2015;114:56–65. - PubMed

Publication types